EFFICACY  OF PNEUMATIC DILATATION FOR THE TREATMENT OF IDIOPATIC ACHALASIA: A SINGLE-CENTRE EXPERIENCE by Sinagra, E. et al.
Abdomen 2015; 2: e512. doi: 10.14800/Abdomen.512; © 2015 by Emanuele Sinagra, et al. 
http://www.smartscitech.com/index.php/Abdomen 
 





Efficacy of pneumatic dilatation for the treatment of idiopatic 
achalasia: a single-center experience 
 
Emanuele Sinagra 1,2,3, Dario Raimondo 1, Luigi Maria Montalbano 4, Cristina Linea 4, Marco Giunta 4, Georgios 
Amvrosiadis 5, Gaetano Cristian Morreale 4, Marco Ciofalo 6, Aroldo Gabriele Rizzo 7, Giovanni Tomasello 8,3, Attilio 
Ignazio Lo Monte 8, Gennaro D’Amico 4 
 
1Gastroenterology and Endoscopy Unit, Fondazione Istituto San Raffaele-G.Giglio, Contrada Pietra Pollastra Pisciotto, 90015 Cefalù, 
Italy 
2PhD course in Surgical Biotechnology and Regenerative Medicine, University of Palermo, Italy 
3Euro-Mediterranean Institute of Science and Technology (IEMEST), Palermo, Italy 
4Ospedali Riuniti Villa Sofia – Vincenzo Cervello, Gastroenterology Unit, via Trabucco 180, 90100, Palermo, Italy 
5DIBIMIS, Ospedali Riuniti Villa Sofia – Vincenzo Cervello, Division of Internal Medicine, via trabucco 180, 90100, Palermo, Italy 
6AOUP Paolo Giaccone, University of Palermo, School of Medicine, Palermo, Italy 
7Ospedali Riuniti Villa Sofia – Vincenzo Cervello, Pathology Unit, via Trabucco 180, 90100, Palermo, Italy 
8Department of Surgical and Oncological Disciplines, School of Medicine, University of Palermo, Italy 
 
Correspondence: Emanuele Sinagra 
E-mail: emanuelesinagra83@googlemail.com 
Received: January 07, 2015 
Published online: March 16, 2015 
 
 
Pneumatic dilatation (PD) and Surgical Miotomy (SM) are presently the best treatments for untreated achalasia, 
with similar efficacy. There is no information on the relative efficacy of PD in younger compared to older patients. 
Aim of our study was to compare success rate and safety of PD in patients under fifty years old and in those over 
fifty years old affected by achalasia. Twenty consecutive symptomatic patients were treated in our Unit with 
graded PD under fluoroscopic view. Five male and 15 female with a median age of 47 years were treated. Twelve 
patients were less than fifty years old (group I) while 8 were older (group II). Median dysphagia questionnaire 
score was 14 and 13 in group I and II respectively. Technical success was achieved in all patients. Seven patients 
were previously treated through other techniques. In group I all patients achieved a complete remission of 
symptoms with significant decrease of the dysphagia questionnaire score (3). In group II all patients achieved a 
complete remission of symptoms with significant decrease of the dysphagia questionnaire score (4.5) but 3 of them 
repeated the procedure. In boths groups the efficacy of the dilation was radiologically confirmed. Neither early 
nor late complications were reported in either groups. In our experience PD was an effective and safe procedure 
both in young and old patients although the older group had more recurrences, all successfully re-dilated. 
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Introduction 
Achalasia is a primary esophageal motility disorder which 
is characterized by impaired relaxation of lower esophageal 
sphincter and aperistalsis of esophagus. Up to now, the 
mainstay of treatment of achalasia is the mechanical 
disruption of the lower esophageal sphincter muscle fibers by 
either endoscopic pneumatic dilation (PD) or surgical 
myotomy (SM), in order to reduce the lower esophageal 
sphincter pressure [1]. 
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However, there is no information on the relative efficacy of 
PD in younger compared to older patients. Aim of our study 
was to compare success rate and safety of PD in patients under 
fifty years old and in those over fifty years old affected by 
achalasia.  
Patients and methods 
Twenty consecutive symptomatic patients were treated in 
our Unit with graded PD trough Rigiflex balloons (®Boston 
Scientific) under fluoroscopic view. All patients were 
previously evaluated with upper endoscopy and x-ray upper 
gastrointestinal transit. When indicated esophageal 
manometry was also performed. All patients signed an 
informed consent and filled in a dysphagia questionnaire 
(table 1) before the procedure. All procedures were performed 
under conscious sedation monitoring blood pressure, heart 
rate and oximetry. Patients were hospitalized and afterwards 
followed-up as outpatients in order to assess the clinical 
benefit or the onset of late complication.   
Five male and 15 female with a median age of 47 years 
(range 21-82) were treated. Twelve patients were less than 
fifty years old (group I) while 8 were older (group II). Median 
dysphagia questionnaire score was 14 and 13 in group I and II 
respectively. Technical success was achieved in all patients 
obtaining a final dilation up to 35 mm. Seven patients were 
previously treated as follow: 4 with medical therapy, 2 trough 
botulin injection and 1 with HM. The median follow-up was 
34.5 months (range 2-120).  
Results 
In group I all patients achieved a complete remission of 
symptoms with significant decrease of the dysphagia 
questionnaire score (median value: 3). In group II all patients 
achieved a complete remission of symptoms with significant 
decrease of the dysphagia questionnaire score (median value: 
4.5) but 3 of them repeated the procedure after a median of 4.5 
months, after the new assessment of Lower Esophageal 
Sphinter (LES) pressure. In both groups the efficacy of the 
dilation was radiologically confirmed. Neither early nor late 
complication were reported in either groups. In group II one 
patient died from esophageal carcinoma (histology before 
dilation was negative) and 1 from gallbladder carcinoma. 
Discussion 
In our experience PD was an effective and safe procedure 
both in young and old patients although the older group had 
more recurrences, all successfully re-dilated.  
Table 1. Dysphagia questionnaire 
1 Difficulty swallowing liquids 0 never 
1 <1 x week 
2 several times/week 
3 every day 
2 Difficulty swallowing solids 0 never 
1 <1 x week 
2 several times/week 
3 every day 
4 several times/ day 
3 Character of swallowing difficulty 0 never 
1 solids sticks briefly 
2 solids only clear with liquids 
3 solids cause vomiting 
4 Present weight 1 increased 
2 same 
3 solids cause vomiting 
5 Chest pain 0 absent 
1 present 
6 extraoesophageal symptoms 0 absent 
1 present 
7 use of PPI 0 none 
1 less than 3 months 
2 more than 3 months 
8 HB 1 >12 
2 10-12 
3 10 -8 
4 <8 
As aforementioned, PD of the LES in patients with 
achalasia is performed to fracture the muscularis propria. PD 
with a rigid balloon across the LES has been shown to be an 
effective and inexpensive technique, while the use of 
bougienage or standard balloon dilation resulted to be 
typically ineffective in achalasia [2,3]. Usually the balloon is 
positioned across the LES using a guidewire and fluoroscopy. 
Investigators have also performed PD through a direct 
visualization rather than fluoroscopy to limit radiation 
exposure as well as to improve clinical remission and 
complications; however no differences were found, in terms 
of complications or response rates, between the two 
techniques [4]  
In our series, no complications were reported. With regards 
to the complications of PD, the principal pitfall is an 
esophageal perforation rate of 2-6% (depending on the series 
and technique) [5], which leads to completion myotomy 
emergently, and the lack of long term efficacy compared with 
SM in most studies [6]  
The role of injection of botulinum toxin injection (EBTI) 
versus pneumatic dilation is currently debated [7,8]. On the 
other hand, the role of PD compared to surgery still represents 
an area of uncertainty. A RCT examining SM versus PD 
showed equivalent results with regards to short-term efficacy, 
but in the long term patients who underwent SM had fewer 
recurrent symptoms than those treated with PD [9]. Some 
studies (but not RCT) suggest that PD may achieve long- term 
relief of symptoms [10] particularly in older patients (>50 years 
old) or when compared retrospectively with SM and, 
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consequently, could be offered as a treatment in this subset of 
patients with achalasia [11].  
Many other studies in literature which concluded old age as 
a predictor of favorable outcome [12]. This is in contrast with 
our study; furthermore, a recent study [12] showed that post-PD 
LES pressure measurement is useful to assess treatment 
response. Patients responding to the first session and those 
with post-PD LES pressure <10 mmHg tended to recur less, 
independently of sex and age, however not considering other 
clinical data.  
Patients who have had treatment for achalasia typically 
have their response measured by improvement of their 
symptoms. However, more objective testing for response had 
been suggested. Manometrically, an LES pressure <10 mmHg 
has been shown to be a precise indicator of a successful SM 
[13].  
Conclusion 
Treatment options for achalasia have traditionally included 
pharmacotherapy such as injections with EBTI, PD and SM. 
Although the last two are considered the mainstay of treatment 
because of higher success rates and relative long-term efficacy 
compared to pharmacotherapy and EBTI, they both are 
associated with a perforation risk of about 1%. SM is the most 
invasive of the procedures, but requiring laparoscopy and 
surgical dissection of the esophagogastric junction. Further 
studies are required to determine the cause of achalasia with 
identifying mechanisms that would facilitate medical 
intervention. Data arising from the literature show that peroral 
endoscopic myotomy (POEM) [14-17] is a technique in 
evolution that does not have a strong evidence base at this 
time. Uncontrolled case series demonstrate that it can improve 
symptoms in patients with achalasia, but that side effects can 
occur commonly. Therefore, the use of POEM for treatment of 
esophageal achalasia is considered investigational. 
In conclusion, further prospective studies, with a larger 
number of patients, are needed in order to assess the impact of 
PD in the clinical course of esophageal achalasia according to 
patients age, and estabilishing a correlation between clinical, 
radiological, functional and endoscopical data. 
Up to now, the therapy of achalasia is based on relaxation 
or mechanical disruption of the LES. Due to the rarity of the 
disease, there are few randomized, controlled clinical trials 
(RCT) that can define the optimal strategy to treat achalasia, 
and consequently the safety, effectiveness, and durability of 
available treatment options vary widely. 
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